Discovery of ATP competitive PDHK1/2 dual inhibitors
- PMID: 40107630
- DOI: 10.1016/j.bmcl.2025.130190
Discovery of ATP competitive PDHK1/2 dual inhibitors
Abstract
Multiple screening approaches were carried out to identify novel chemistry starting for Pyruvate Dehydrogenase Kinases (PDHKs) inhibitors. Through hit triaging efforts and structure-based optimization, two series of ATP competitive inhibitors with single digit nanomolar enzymatic potency for PDHK1/2 and around 10-100-fold selectivity over PDHK4/3 were discovered. Approach of covalent inhibitor was explored to successfully improve the cellular target engagement to single digit micromolar range.
Keywords: Covalent inhibitor; Kinase inhibitors for immunometabolism; Structure based design.
Copyright © 2025 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The majority of the authors are currently employed by Roche and may hold shares in the company. This affiliation may present a potential conflict of interest. However, we affirm that the research was conducted with the highest standards of scientific integrity and objectivity. The findings and conclusions presented in this manuscript are solely based on the data and analysis performed during the study.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources